Gideon Capital Advisors’s Bausch Health BHC Stock Holding History

Gideon Capital Advisors’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-27,819	Closed	-$608K	–	269
2019 Q3	$608K	Buy	+27,819	New	+$636K	0.2%	163
2019 Q2	–	Sell	-19,407	Closed	-$479K	–	280
2019 Q1	$479K	Sell	19,407 -5,416	-22%	-$129K	0.17%	179
2018 Q4	$458K	Buy	+24,823	New	+$590K	0.19%	171
2018 Q3	–	Sell	-17,872	Closed	-$415K	–	348
2018 Q2	$415K	Buy	+17,872	New	+$370K	0.21%	185
2017 Q1	–	Sell	-41,719	Closed	-$606K	–	397
2016 Q4	$606K	Buy	+41,719	New	+$765K	0.39%	54

Other funds holding BHC

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Gideon Capital Advisors's BHC Position: Q4 2019 in Review

Gideon Capital Advisors sold out of Bausch Health (BHC) in Q4 2019, closing a stake of 27,819 shares — an estimated $608K sold.

Gideon Capital Advisors first reported a position in BHC in Q4 2016 and held it in 5 quarters. The position peaked at $608K in Q3 2019. 327 funds tracked by Wall St. Rank hold BHC as of Q4 2019.

Gideon Capital Advisors reported no remaining Bausch Health position as of Q4 2019 after selling out during the quarter.
Gideon Capital Advisors sold 27,819 Bausch Health shares in Q4 2019, an estimated $608K.
Gideon Capital Advisors first reported a position in Bausch Health in Q4 2016 and held it in 5 quarters.
Gideon Capital Advisors's Bausch Health position peaked at $608K in Q3 2019.
327 funds tracked by Wall St. Rank held Bausch Health as of Q4 2019.

Based on Gideon Capital Advisors's 13F filing for Q4 2019, filed 11 Feb 2020.